Corton Capital Inc. Alnylam Pharmaceuticals, Inc. Transaction History

Corton Capital Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$146.51 - $198.2 $267,087 - $361,318	-1,823 Reduced 37.77%	3,004 $448,000
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $528,269 - $685,832	3,489 Added 260.76%	4,827 $923,000
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $265,205 - $328,692	-1,553 Reduced 53.72%	1,338 $236,000
Q2 2023 Aug 14, 2023	BUY	$185.01 - $212.05 $534,863 - $613,036	2,891 New	2,891 $549,000

663

109M

1.28M

1.23M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $34B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.